TY - JOUR AU - Abifadel, M. AU - Varret, M. AU - Rabes, J. P. AU - Allard, D. AU - Ouguerram, K. AU - Devillers, M. PY - 2003 DA - 2003// TI - Mutations in PCSK9 cause autosomal dominant hypercholesterolemia JO - Nat Genet VL - 34 UR - https://doi.org/10.1038/ng1161 DO - 10.1038/ng1161 ID - Abifadel2003 ER - TY - JOUR AU - Arbabi-Ghahroudi, M. AU - Tanha, J. AU - MacKenzie, R. PY - 2005 DA - 2005// TI - Prokaryotic expression of antibodies JO - Cancer Metast Rev VL - 24 UR - https://doi.org/10.1007/s10555-005-6193-1 DO - 10.1007/s10555-005-6193-1 ID - Arbabi-Ghahroudi2005 ER - TY - JOUR AU - Arbabi Ghahroudi, M. AU - Desmyter, A. AU - Wyns, L. AU - Hamers, R. AU - Muyldermans, S. PY - 1997 DA - 1997// TI - Selection and identification of single domain antibody fragments from camel heavy-chain antibodies JO - FEBS Lett VL - 414 UR - https://doi.org/10.1016/S0014-5793(97)01062-4 DO - 10.1016/S0014-5793(97)01062-4 ID - Arbabi Ghahroudi1997 ER - TY - JOUR AU - Arbel, R. AU - Hammerman, A. AU - Triki, N. AU - Greenberg, D. PY - 2016 DA - 2016// TI - PCSK9 inhibitors may improve cardiovascular outcomes-Can we afford them? JO - Int J Cardiol VL - 220 UR - https://doi.org/10.1016/j.ijcard.2016.06.126 DO - 10.1016/j.ijcard.2016.06.126 ID - Arbel2016 ER - TY - JOUR AU - Chames, P. AU - Regenmortel, M. AU - Weiss, E. AU - Baty, D. PY - 2009 DA - 2009// TI - Therapeutic antibodies: successes, limitations and hopes for the future JO - Br J Pharmacol VL - 157 UR - https://doi.org/10.1111/j.1476-5381.2009.00190.x DO - 10.1111/j.1476-5381.2009.00190.x ID - Chames2009 ER - TY - JOUR AU - Baigent, C. AU - Blackwell, L. AU - Emberson, J. AU - Holland, L. E. AU - Reith, C. PY - 2010 DA - 2010// TI - Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials JO - Lancet. VL - 376 UR - https://doi.org/10.1016/s0140-6736(10)61350-5 DO - 10.1016/s0140-6736(10)61350-5 ID - Baigent2010 ER - TY - JOUR AU - Coppieters, K. AU - Dreier, T. AU - Silence, K. AU - Haard, H. AU - Lauwereys, M. AU - Casteels, P. PY - 2006 DA - 2006// TI - Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.21827 DO - 10.1002/art.21827 ID - Coppieters2006 ER - TY - JOUR AU - Djender, S. AU - Schneider, A. AU - Beugnet, A. AU - Crepin, R. AU - Desrumeaux, K. E. AU - Romani, C. PY - 2014 DA - 2014// TI - Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies JO - Microb Cell Fact VL - 13 UR - https://doi.org/10.1186/s12934-014-0140-1 DO - 10.1186/s12934-014-0140-1 ID - Djender2014 ER - TY - JOUR AU - Essalmani, R. AU - Weider, E. AU - Marcinkiewicz, J. AU - Chamberland, A. AU - Susan-Resiga, D. AU - Roubtsova, A. PY - 2018 DA - 2018// TI - A single domain antibody against the Cys- and His-rich domain of PCSK9 and evolocumab exhibit different inhibition mechanisms in humanized PCSK9 mice JO - Biol Chem VL - 399 UR - https://doi.org/10.1515/hsz-2018-0194 DO - 10.1515/hsz-2018-0194 ID - Essalmani2018 ER - TY - JOUR AU - Frenken, L. G. AU - Linden, R. H. AU - Hermans, P. W. AU - Bos, J. W. AU - Ruuls, R. C. AU - Geus, B. PY - 2000 DA - 2000// TI - Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae JO - J Biotechnol VL - 78 UR - https://doi.org/10.1016/S0168-1656(99)00228-X DO - 10.1016/S0168-1656(99)00228-X ID - Frenken2000 ER - TY - JOUR AU - Glockshuber, R. AU - Malia, M. AU - Pfitzinger, I. AU - Pluckthun, A. PY - 1990 DA - 1990// TI - A comparison of strategies to stabilize immunoglobulin Fv-fragments JO - Biochemistry VL - 29 UR - https://doi.org/10.1021/bi00458a002 DO - 10.1021/bi00458a002 ID - Glockshuber1990 ER - TY - JOUR AU - Goncalves, A. M. AU - Pedro, A. Q. AU - Maia, C. AU - Sousa, F. AU - Queiroz, J. A. AU - Passarinha, L. A. PY - 2013 DA - 2013// TI - Pichia pastoris: a recombinant microfactory for antibodies and human membrane proteins JO - J Microbiol Biotechnol VL - 23 UR - https://doi.org/10.4014/jmb.1210.10063 DO - 10.4014/jmb.1210.10063 ID - Goncalves2013 ER - TY - JOUR AU - Hofmann, S. L. AU - Russell, D. W. AU - Brown, M. S. AU - Goldstein, J. L. AU - Hammer, R. E. PY - 1988 DA - 1988// TI - Overexpression of low density lipoprotein (LDL) receptor eliminates LDL from plasma in transgenic mice JO - Science VL - 239 UR - https://doi.org/10.1126/science.3344433 DO - 10.1126/science.3344433 ID - Hofmann1988 ER - TY - JOUR AU - Jorgensen, M. L. AU - Friis, N. A. AU - Just, J. AU - Madsen, P. AU - Petersen, S. V. AU - Kristensen, P. PY - 2014 DA - 2014// TI - Expression of single-chain variable fragments fused with the Fc-region of rabbit IgG in Leishmania tarentolae JO - Microb Cell Fact VL - 13 UR - https://doi.org/10.1186/1475-2859-13-9 DO - 10.1186/1475-2859-13-9 ID - Jorgensen2014 ER - TY - JOUR AU - Kontermann, R. E. PY - 2016 DA - 2016// TI - Half-life extended biotherapeutics JO - Expert Opin Biol Therapy VL - 16 UR - https://doi.org/10.1517/14712598.2016.1165661 DO - 10.1517/14712598.2016.1165661 ID - Kontermann2016 ER - TY - JOUR AU - Lagace, T. A. AU - Curtis, D. E. AU - Garuti, R. AU - McNutt, M. C. AU - Park, S. W. AU - Prather, H. B. PY - 2006 DA - 2006// TI - Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice JO - J Clin Investig VL - 116 UR - https://doi.org/10.1172/JCI29383 DO - 10.1172/JCI29383 ID - Lagace2006 ER - TY - JOUR AU - Larsen, S. AU - Stride, N. AU - Hey-Mogensen, M. AU - Hansen, C. N. AU - Bang, L. E. AU - Bundgaard, H. PY - 2013 DA - 2013// TI - Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance JO - J Am Coll Cardiol VL - 61 UR - https://doi.org/10.1016/j.jacc.2012.09.036 DO - 10.1016/j.jacc.2012.09.036 ID - Larsen2013 ER - TY - JOUR AU - Lebozec, K. AU - Jandrot-Perrus, M. AU - Avenard, G. AU - Favre-Bulle, O. AU - Billiald, P. PY - 2018 DA - 2018// TI - Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: a case study prior to pharmaceutical development JO - New Biotechnol VL - 44 UR - https://doi.org/10.1016/j.nbt.2018.04.006 DO - 10.1016/j.nbt.2018.04.006 ID - Lebozec2018 ER - TY - JOUR AU - Li, X. AU - Duan, X. AU - Yang, K. AU - Zhang, W. AU - Zhang, C. AU - Fu, L. PY - 2016 DA - 2016// TI - Comparative analysis of immune repertoires between bactrian camel’s conventional and heavy-chain antibodies JO - PLoS ONE VL - 11 UR - https://doi.org/10.1371/journal.pone.0161801 DO - 10.1371/journal.pone.0161801 ID - Li2016 ER - TY - JOUR AU - Lipari, M. T. AU - Li, W. AU - Moran, P. AU - Kong-Beltran, M. AU - Sai, T. AU - Lai, J. PY - 2012 DA - 2012// TI - Furin-cleaved proprotein convertase subtilisin/kexin type 9 (PCSK9) is active and modulates low density lipoprotein receptor and serum cholesterol levels JO - J Biol Chem VL - 287 UR - https://doi.org/10.1074/jbc.M112.380618 DO - 10.1074/jbc.M112.380618 ID - Lipari2012 ER - TY - JOUR AU - Mayne, J. AU - Dewpura, T. AU - Raymond, A. AU - Cousins, M. AU - Chaplin, A. AU - Lahey, K. A. PY - 2008 DA - 2008// TI - Plasma PCSK9 levels are significantly modified by statins and fibrates in humans JO - Lipids Health Dis VL - 7 UR - https://doi.org/10.1186/1476-511X-7-22 DO - 10.1186/1476-511X-7-22 ID - Mayne2008 ER - TY - JOUR AU - Muda, M. AU - Gross, A. W. AU - Dawson, J. P. AU - He, C. AU - Kurosawa, E. AU - Schweickhardt, R. PY - 2011 DA - 2011// TI - Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodies JO - Protein Eng Des Select VL - 24 UR - https://doi.org/10.1093/protein/gzq123 DO - 10.1093/protein/gzq123 ID - Muda2011 ER - TY - JOUR AU - Petrilli, W. L. AU - Adam, G. C. AU - Erdmann, R. S. AU - Abeywickrema, P. AU - Agnani, V. AU - Ai, X. PY - 2019 DA - 2019// TI - From screening to targeted degradation: strategies for the discovery and optimization of small molecule ligands for PCSK9 JO - Cell Chem Biol UR - https://doi.org/10.1016/j.chembiol.2019.10.002 DO - 10.1016/j.chembiol.2019.10.002 ID - Petrilli2019 ER - TY - JOUR AU - Peyvandi, F. AU - Scully, M. AU - Kremer Hovinga, J. A. AU - Knobl, P. AU - Cataland, S. AU - Beuf, K. PY - 2017 DA - 2017// TI - Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura JO - J Thromb Haemost VL - 15 UR - https://doi.org/10.1111/jth.13716 DO - 10.1111/jth.13716 ID - Peyvandi2017 ER - TY - JOUR AU - Roth, E. M. AU - Davidson, M. H. PY - 2018 DA - 2018// TI - PCSK9 Inhibitors: mechanism of Action, Efficacy, and Safety JO - Rev Cardiovasc Med VL - 19 ID - Roth2018 ER - TY - JOUR AU - Saremi, A. AU - Bahn, G. AU - Reaven, P. D. AU - Investigators, V. PY - 2012 DA - 2012// TI - Progression of vascular calcification is increased with statin use in the Veterans Affairs Diabetes Trial (VADT) JO - Diabetes Care VL - 35 UR - https://doi.org/10.2337/dc12-0464 DO - 10.2337/dc12-0464 ID - Saremi2012 ER - TY - JOUR AU - Scognamiglio, M. AU - Costa, D. AU - Sorriento, A. AU - Napoli, C. PY - 2019 DA - 2019// TI - Current therapy and nutraceuticals for the treatment of patients with dyslipidemias JO - Curr Pharm Des UR - https://doi.org/10.2174/1381612825666190130101108 DO - 10.2174/1381612825666190130101108 ID - Scognamiglio2019 ER - TY - JOUR AU - Seidah, N. G. AU - Benjannet, S. AU - Wickham, L. AU - Marcinkiewicz, J. AU - Jasmin, S. B. AU - Stifani, S. PY - 2003 DA - 2003// TI - The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation JO - Proc Natl Acad Sci USA VL - 100 UR - https://doi.org/10.1073/pnas.0335507100 DO - 10.1073/pnas.0335507100 ID - Seidah2003 ER - TY - JOUR AU - Shen, Y. AU - Li, H. AU - Zhao, L. AU - Li, G. AU - Chen, B. AU - Guo, Q. PY - 2017 DA - 2017// TI - Increased half-life and enhanced potency of Fc-modified human PCSK9 monoclonal antibodies in primates JO - PLoS ONE VL - 12 UR - https://doi.org/10.1371/journal.pone.0183326 DO - 10.1371/journal.pone.0183326 ID - Shen2017 ER - TY - JOUR AU - Shimano, H. AU - Horton, J. D. AU - Hammer, R. E. AU - Shimomura, I. AU - Brown, M. S. AU - Goldstein, J. L. PY - 1996 DA - 1996// TI - Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a JO - J Clin Investig VL - 98 UR - https://doi.org/10.1172/JCI118951 DO - 10.1172/JCI118951 ID - Shimano1996 ER - TY - JOUR AU - Taylor, B. A. AU - Thompson, P. D. PY - 2016 DA - 2016// TI - Statins and their effect on PCSK9-impact and clinical relevance JO - Curr Atheroscler Rep VL - 18 UR - https://doi.org/10.1007/s11883-016-0604-3 DO - 10.1007/s11883-016-0604-3 ID - Taylor2016 ER - TY - JOUR AU - Vincke, C. AU - Gutierrez, C. AU - Wernery, U. AU - Devoogdt, N. AU - Hassanzadeh-Ghassabeh, G. AU - Muyldermans, S. PY - 2012 DA - 2012// TI - Generation of single domain antibody fragments derived from camelids and generation of manifold constructs JO - Methods Mol Biol VL - 907 UR - https://doi.org/10.1007/978-1-61779-974-7_8 DO - 10.1007/978-1-61779-974-7_8 ID - Vincke2012 ER - TY - JOUR AU - Weider, E. AU - Susan-Resiga, D. AU - Essalmani, R. AU - Hamelin, J. AU - Asselin, M. C. AU - Nimesh, S. PY - 2016 DA - 2016// TI - Proprotein convertase subtilisin/kexin type 9 (PCSK9) single domain antibodies are potent inhibitors of low density lipoprotein receptor degradation JO - J Biol Chem VL - 291 UR - https://doi.org/10.1074/jbc.M116.717736 DO - 10.1074/jbc.M116.717736 ID - Weider2016 ER - TY - JOUR AU - Weider, E. AU - Susan-Resiga, D. AU - Essalmani, R. AU - Hamelin, J. AU - Asselin, M. C. AU - Nimesh, S. PY - 2016 DA - 2016// TI - Proprotein convertase subtilisin/kexin type 9 (PCSK9) single domain antibodies are potent inhibitors of low density lipoprotein receptor degradation JO - J Biol Chem VL - 291 UR - https://doi.org/10.1074/jbc.A116.717736 DO - 10.1074/jbc.A116.717736 ID - Weider2016 ER - TY - JOUR AU - Ylera, F. AU - Harth, S. AU - Waldherr, D. AU - Frisch, C. AU - Knappik, A. PY - 2013 DA - 2013// TI - Off-rate screening for selection of high-affinity anti-drug antibodies JO - Anal Biochem VL - 441 UR - https://doi.org/10.1016/j.ab.2013.07.025 DO - 10.1016/j.ab.2013.07.025 ID - Ylera2013 ER - TY - JOUR AU - Zhang, Y. AU - Ultsch, M. AU - Skelton, N. J. AU - Burdick, D. J. AU - Beresini, M. H. AU - Li, W. PY - 2017 DA - 2017// TI - Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists JO - Nat Struct Mol Biol VL - 24 UR - https://doi.org/10.1038/nsmb.3453 DO - 10.1038/nsmb.3453 ID - Zhang2017 ER -